Efficacy of IgG and F(ab′) 2 antivenoms to neutralize snake venom-induced local tissue damage as assessed by the proteomic analysis of wound exudate

Journal of Proteome Research

Volumn 11, Issue 1, 2012, Pages 292-305

  Rucavado, Alexandra ^a   Escalante, Teresa ^a   Shannon, John D ^b   Ayala Castro, Carla N ^b   Villalta, Mauren ^a   Gutiérrez, José María ^a   Fox, Jay W ^b  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

antivenom; Bothrops asper; extracellular matrix; F(ab0)2; hemorrhage; IgG; myonecrosis; proteomics; Snake venom; wound exudate

Indexed keywords

F(AB')2 ANTIVENOM; IMMUNOGLOBULIN G; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; DRUG MECHANISM; ENVENOMATION; EXTRACELLULAR MATRIX; EXUDATE; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SNAKE; WOUND;

ANIMALS; ANTIVENINS; BLOOD PROTEINS; BOTHROPS; CROTALID VENOMS; EXTRACELLULAR MATRIX PROTEINS; EXUDATES AND TRANSUDATES; HEMORRHAGE; HORSES; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MICE; MUSCLE, SKELETAL; PROTEOME; PROTEOMICS;

BOTHROPS ASPER; EQUIDAE; MUS;

EID: 84855554501     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200847q     Document Type: Article

References (66)

1. Otero, R.; Gutiérrez, J.; Mesa, M. B.; Duque, E.; Rodríguez, O.; Arango, L. J.; Gómez, F.; Toro, A.; Cano, F.; Rodríguez, M. L.; Caro, E.; Martínez, J.; Cornejo, W.; Gómez, L. M.; Uribe, L. F.; Cárdenas, S.; Núñez, V.; Díaz, A. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital Toxicon 2002, 40, 1107-1114
2. Warrell, D. A. Epidemiology, clinical features and management of snake bites in Central and South America. In The Venomous Reptiles of the Western Hemisphere, Vol 2; Campbell, J. A.; Lamar, W. W., Eds.; Cornell University Press: Ithaca, NY, 2004; pp 709-761.
3. Lomonte, B.; Lundgren, J.; Johansson, B.; Bagge, U. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study Toxicon 1994, 32, 41-55 (Pubitemid 24047960)
4. 2: insights into the mechanisms of local and systemic myotoxicity Toxicon 2003, 42, 915-931 (Pubitemid 38201492)
5. Gutiérrez, J. M.; Rucavado, A.; Chaves, F.; Díaz, C.; Escalante, T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom Toxicon 2009, 54, 958-975
6. 2 myotoxins and neurotoxins: common aspects of their mechanisms of action Cell. Mol. Life Sci. 2008, 65, 2897-2912
7. Mora, J.; Mora, R.; Lomonte, B.; Gutiérrez, J. M. Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation PLoS Negl. Trop. Dis. 2008, 2, e318
8. Fox, J. W.; Serrano, S. M. T. Structural consideration of the snake venom metalloproteinases, key members of the M12 reprolysisn family of metalloproteinases Toxicon 2005, 45, 969-985 (Pubitemid 40732574)
9. Escalante, T.; Rucavado, A.; Fox, J. W.; Gutiérrez, J. M. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases J. Proteomics 2011, 74, 1781-1794
10. Teixeira, C. F. P.; Cury, Y.; Moreira, V.; Picolo, G.; Chaves, F. Inflammation induced by Bothrops asper venom Toxicon 2009, 54, 988-997
11. Escalante, T.; Rucavado, A.; Pinto, A. F. M.; Terra, R. M. S.; Gutiérrez, J. M.; Fox, J. W. Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins J. Proteome Res. 2009, 8, 5120-5131
12. Rucavado, A.; Escalante, T.; Shannon, J.; Gutiérrez, J. M.; Fox, J. W. Proteomics of wound exudate in snake venom-induced pathology: search for biomarkers to assess tissue damage and therapeutic success J. Proteome Res. 2011, 10, 1987-2005
13. Eming, S. A.; Koch, M.; Krieger, A.; Brachvogel, B; Kreft, S.; Bruckner-Tuderman, L.; Krieg, T.; Shannon, J. D.; Fox, J. W. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds J. Proteome Res. 2010, 9, 4758-4766
14. Ahn, S. M.; Simpson, R. J. Body fluid proteomics: Prospects for biomarker discovery Proteomics Clin. Appl. 2007, 1, 1004-1015
15. Fernández, M. L.; Broadbent, J. A.; Shooter, G. K.; Malda, J.; Upton, Z. Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid Br. J. Dermatol. 2008, 158, 281-290
16. World Health Organization. Rabies and Envenomings: A Neglected Public Health Issue; World Health Organization: Geneva, 2007.
17. World Health Organization. WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins; World Health Organization: Geneva, 2010.
18. Gutiérrez, J. M.; León, G.; Burnouf, T. Antivenoms for the treatment of snakebite envenomings: the road ahead Biologicals 2011, 39, 129-142
19. Otero, R.; Gutiérrez, J. M.; Rojas, G.; Núñez, V.; Díaz, A.; Miranda, E.; Uribe, A. F.; Silva, J. F.; Ospina, J. G.; Medina, Y.; Toro, M. F.; García, M. E.; León, G.; García, M.; Lizano, S.; De La Torre, J.; Márquez, J.; Mena, Y.; González, N.; Arenas, L. C.; Puzón, A.; Blanco, N.; Sierra, A.; Espinal, M. E.; Arboleda, M.; Jiménez, J. C.; Ramírez, P.; Díaz, M.; Guzmán, M. C.; Barros, J.; Henao, S.; Ramírez, A.; Macea, U.; Lozano, R. A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms Toxicon 1999, 37, 895-908 (Pubitemid 29155276)
20. Dart, R. C.; Seifert, S. A.; Boyer, L. V.; Clark, R. F.; Hall, E.; McKinney, P.; McNally, J.; Kitchens, C. S.; Curry, S. C.; Bogdan, G. M.; Ward, S. B.; Porter, R. S. A randomized multicenter trial of crotaline polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States Arch. Intern. Med. 2001, 161, 2030-2036
21. Lalloo, D. G.; Theakston, R. D. G. Snake antivenoms J. Toxicol. Clin. Toxicol. 2003, 41, 277-290 (Pubitemid 36676578)
22. Smalligan, R.; Cole, J.; Brito, N.; Laing, G. D.; Mertz, B. L.; Manock, S.; Maudlin, J.; Quist, B.; Holland, G.; Nelson, S.; Lalloo, D. G.; Rivadeneira, G.; Barragan, M. E.; Dolley, D.; Eddleston, M.; Warrell, D. A.; Theakston, R. D. G. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms Br. Med. J. 2004, 329, 1129
23. Abubakar, I. S.; Abubakar, S. B.; Habib, A. G.; Nasidi, A.; Durfa, N.; Yusuf, P. O.; Larnyang, S.; Garnvwa, J.; Sokomba, E.; Salako, L.; Theakston, R. D. G.; Juszczak, E.; Alder, N.; Warrell, D. A. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria PLoS Negl. Trop. Dis. 2010, 4, e767
24. Warrell, D. A. The global problem of snake bite: Its prevention and treatment. In Recent Advances in Toxinology Research, Vol 1; Gopalakrishnakone, P.; Tan, C. K., Eds.; National University of Singapore: Singapore, 1992; pp 121-153.
25. Campbell, J.; Lamar, W. W. The Venomous Reptiles of the Western Hemisphere; Cornell University Press: Ithaca, NY, 2004.
26. Otero-Patiño, R. Epidemiological, clinical and therapeutic aspects of Bothrops asper bites Toxicon 2009, 54, 998-1011
27. Gutiérrez, J. M. Snakebite envenomation in Central America. In Handbook of Venoms and Toxins of Reptiles; MacKessy, S. P., Ed.; CRC Press: Boca Raton, FL, 2010; pp 491-507.
28. Gutiérrez, J. M.; Chaves, F.; Bolaños, R.; Cerdas, L.; Rojas, E.; Arroyo, O.; Portilla, E. Neutralización de los efectos locales del veneno de Bothrops asper por un antiveneno polivalente Toxicon 1981, 19, 493-500 (Pubitemid 11009000)
29. Gutiérrez, J. M.; León, G.; Rojas, G.; Lomonte, B.; Rucavado, A.; Chaves, F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom Toxicon 1998, 36, 1529-1538 (Pubitemid 28511067)
30. Rucavado, A.; Lomonte, B. Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice Toxicon 1996, 34, 567-577 (Pubitemid 26164344)
31. Angulo, Y.; Estrada, R.; Gutiérrez, J. M. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom Toxicon 1997, 35, 81-90 (Pubitemid 27037988)
32. Rojas, G.; Jiménez, J. M.; Gutiérrez, J. M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production Toxicon 1994, 32, 351-363 (Pubitemid 24104444)
33. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom Toxicon 1997, 35, 1627-1637 (Pubitemid 27511703)
34. Gutiérrez, J. M.; Gené, J. A.; Rojas, G.; Cerdas, L. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom Toxicon 1985, 23, 887-893 (Pubitemid 16207989)
35. Gutiérrez, J. M.; Ownby, C. L.; Odell, G. V. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper Exp. Mol. Pathol. 1984, 40, 367-379 (Pubitemid 14083864)
36. Moreira, L.; Gutiérrez, J. M.; Borkow, G.; Ovadia, M. Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper Exp. Mol. Pathol. 1992, 57, 124-133
37. Bjarnason, J. B.; Fox, J. W. Hemorrhagic metalloproteinases from snake venoms Pharmac. Ther. 1994, 62, 325-372 (Pubitemid 24248422)
38. Jiménez, N.; Escalante, N.; Gutiérrez, J. M.; Rucavado, A. Skin pathology induced by snake venom metalloproteinase: acute damage, revascularization and re-epithelization in a mouse ear model J. Invest. Dermatol. 2008, 128, 2421-2428
39. Theakston, R. D. G.; Warrell, D. A.; Griffiths, E. Report of a WHO workshop on the standardization and control of antivenoms Toxicon 2003, 41, 541-557 (Pubitemid 36379293)
40. Gutiérrez, J. M.; Rojas, G.; Bogarín, G.; Lomonte, B. Evaluation of the neutralizing ability of antivenoms for the treatment of snake bite envenoming in Central America. In Envenomings and Their Treatments; Bon, C.; Goyffon, M., Eds.; Fondation Marcel Mérieux: Lyon, 1996; pp 223-231.
41. Lomonte, B.; León, G.; Angulo, Y.; Rucavado, A.; Núñez, V. Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: Contributions to understanding snakebite envenomings and their treatment Toxicon 2009, 54, 1012-1028
42. Battellino, C.; Piazza, R.; da Silva, A. M.; Cury, Y.; Farsky, S. H. P. Assessment of efficacy of bothropic antivenom therapy on microcirculatory effects induced by Bothrops jararaca snake venom Toxicon 2003, 41, 583-593 (Pubitemid 36379297)
43. León, G.; Valverde, J. M.; Rojas, G.; Lomonte, B.; Gutiérrez, J. M. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom Toxicon 2000, 38, 233-244 (Pubitemid 29512195)
44. Zhang, Q.; Menon, R.; Deutsch, E. W.; Pitteri, S. J.; Faca, V. M.; Wang, H.; Newcomb, L. S.; DePinho, R. A.; Bardeesy, N.; Dinulescu, D.; Hung, K. E.; Kucherlapati, R.; Jacks, T.; Politi, K.; Aebersold, R.; Omenn, G. S.; States, D. J.; Hanash, S. M. A mouse plasma peptide atlas as a resource for disease proteomics Genome Biol. 2008, 9, R93
45. Gutiérrez, J. M.; Sanz, L.; Flores-Díaz, M.; Figueroa, L.; Madrigal, M.; Herrera, M.; Villalta, M.; León, G.; Estrada, R.; Borges, A.; Alape-Girón, A.; Calvete, J. J. Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: Integrating antivenomics and neutralization approaches J. Proteome Res. 2010, 9, 564-577
46. Weiss, L. Histology. Cell and Tissue Biology; Elsevier Biomedical: New York, 1983.
47. Serrano, S. M. T.; Jia, L. G.; Wang, D.; Shannon, J. D.; Fox, J. W. Function of the cysteine-rich domain of the hemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor Biochem. J. 2005, 391, 69-76 (Pubitemid 41445477)
48. Escalante, T.; Shannon, J.; Moura-da-Silva, A. M.; Gutiérrez, J. M.; Fox, J. W. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: A biochemical and immunohistochemical study Arch. Biochem. Biophys. 2006, 455, 144-153 (Pubitemid 44708849)
49. Costell, M.; Gustafsson, E.; Aszódi, A.; Mörgelin, M.; Bloch, W.; Hunziker, E.; Addicks, K.; Timpl, R.; Fässler, R. 1999. Perlecan maintains the integrity of cartilage and some basement membranes J. Cell Biol. 1999, 147, 1109-1122
50. Yurchenco, P. D.; Amenta, P. S.; Patton, B. L. Basement membrane assembly, stability and activities observed through a developmental lens Matrix Biol. 2004, 22, 521-538 (Pubitemid 38283776)
51. Pöschl, E.; Schlötzer-Schrehardt, U.; Brachvogel, B.; Saito, K.; Ninomiya, Y.; Mayer, U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development Development 2004, 131, 1619-1628 (Pubitemid 38559288)
52. Iozzo, R. V. Basement membrane proteoglycans: from cellar to ceiling Nat. Rev. Mol. Cell Biol. 2005, 6, 646-656 (Pubitemid 41081268)
53. Voermans, N. C.; Verrijp, K.; Eshuis, L.; Balemans, M. C. M.; Egging, D.; Sterrenburg, E.; van Rooij, I. A. L. M.; van der Laak, J. A. W. M.; Schalkwijk, J.; van der Maarel, S. M.; Lammens, M.; van Engelen, B. G. Mild muscular features in Tenascin-X knockout mice, a model of Ehlers-Danlos Syndrome. Connect. Tissue Res. 2011, in press.
54. Bristow, J.; Carey, W.; Egging, D.; Schalkwijk, J. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome Am. J. Med. Genet. C Semin. Med. Genet. 2005, 139C, 24-30 (Pubitemid 41739244)
55. Margaron, Y.; Bostan, L.; Exposito, J. Y.; Malbouyres, M.; Trunfio-Sfarghiu, A. M.; Bertheir, Y.; Lethias, C. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis Biophys. Chem. 2010, 147, 87-91
56. Minamitami, T.; Ariga, H.; Matsumoto, K. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen Exp. Cell Res. 2004, 297, 49-60 (Pubitemid 38759561)
57. Rucavado, A.; Escalante, T.; Teixeira, C. F. P.; Fernandes, C. M.; Díaz, C.; Gutiérrez, J. M. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper Med. Inflamm. 2002, 11, 121-128 (Pubitemid 34526416)
58. Saravia-Otten, P.; Frisan, T.; Thelestam, M.; Gutiérrez, J. M. Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases Toxicon 2004, 44, 749-764 (Pubitemid 39410350)
59. Gutiérrez, J. M.; Rojas, G.; Lomonte, B.; Gené, J. A.; Cerdas, L. Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom Comp. Biochem. Physiol. C 1986, 85, 171-175
60. Lomonte, B. Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom Toxicon 1985, 23, 173-176 (Pubitemid 15172300)
61. Picolo, G.; Chacur, M.; Gutiérrez, J. M.; Teixeira, C. F. P.; Cury, Y. Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms Braz. J. Med. Biol. Res. 2002, 35, 1221-1228 (Pubitemid 36013571)
62. Ho, M.; Silamut, K.; White, N. J.; Karbwang, J.; Looareesuwan, S.; Phillips, R. E.; Warrell, D. A. Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand Am. J. Trop. Med. Hyg. 1990, 42, 260-266 (Pubitemid 20109050)
63. Ismail, M.; Abd-Elsalam, M. A. Serotherapy of scorpion envenoming: Pharmacokinetics of antivenoms and a critical assessment of their usefulness. In Envenomings and Their Treatments; Bon, C.; Goyffon, M., Eds.; Fondation Marcel Mérieux: Lyon, 1996; pp 135-153.
64. Scherrmann, J. M. Antibody treatment of toxin poisoning- recent advances J. Toxicol. Clin. Toxicol. 1994, 32, 363-375
65. Gutiérrez, J. M.; León, G.; Lomonte, B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation Clin. Pharmacokinet. 2003, 42, 721-741 (Pubitemid 36976120)
66. 2 antivenoms in the neutralisation of hemorrhagic activity of Vipera berus snake venom in mice Toxicon 1996, 34, 1197-1202 (Pubitemid 26365148)